
Analysts predict blockbuster status for first-in-class

Food allergies could open up big new market for biologic

Will put an additional $1bn in investigational candidate cemiplimab

Abandons phase IIb trial of house dust mite allergy candidate

Reframing the conversation from disease burden to prevention and health promotion
Saycomms looks into the seasonal trend of allergies stories in the media and the communication campaigns launched in UK in 2015.

Accepts application for oral tablet to protect against ragweed-based allergies

Companies will develop three immunotherapies targeting different allergens

Ziarco headed by former Pfizer chief scientific officer, allergy and respiratory research, Mike Yeadon